LATHIAN SYSTEMS, INC. – Trademark Portfolio
Entity Type: 03
LATHIAN SYSTEMS, INC. holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 3 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 4 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include MYDRUGREP.COM. The owner is based in NEWPORT BEACH, CA.
4590 MACARTHUR BLVD.
NEWPORT BEACH, CA 92660
Showing of trademarks Trademarks
Trademark Classifications
LATHIAN SYSTEMS, INC.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Advertising; business management; business administration; office functions
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does LATHIAN SYSTEMS, INC. have?
LATHIAN SYSTEMS, INC. has 5 U.S. trademarks filed with the USPTO. Of these, 1 registered, 4 cancelled.
What trademark classes does LATHIAN SYSTEMS, INC. file in?
LATHIAN SYSTEMS, INC. files trademarks across 4 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 35 (Advertising & Business), Class 9 (Computers & Electronics), Class 38 (Telecommunications). Class 42 covers scientific and technological services; industrial analysis and research services.
What are LATHIAN SYSTEMS, INC.'s most well-known trademarks?
LATHIAN SYSTEMS, INC.'s registered trademark portfolio includes well-known marks such as MYDRUGREP.COM. These are among 1 currently registered trademark in the portfolio.
What is LATHIAN SYSTEMS, INC.'s trademark registration success rate?
LATHIAN SYSTEMS, INC. has a 20% trademark registration rate, with 1 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.